middle.news
Mesoblast Launches Ryoncil in US, Bolsters Cash and Clinical Pipeline
4:43am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Mesoblast Launches Ryoncil in US, Bolsters Cash and Clinical Pipeline
4:43am on Monday 2nd of June, 2025 AEST
Key Points
Ryoncil commercially available in US with Medicaid coverage
US$182 million cash on hand supports expansion plans
Ongoing FDA discussions for accelerated approval of Revascor
Phase 3 trial underway for rexlemestrocel-L in chronic low back pain
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MSB
OPEN ARTICLE